HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
2 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
VWC2L
von Willebrand factor C domain containing 2 like
Chromosome 2 · 2q34-q35
NCBI Gene: 402117Ensembl: ENSG00000174453.10HGNC: HGNC:37203UniProt: B2RUY7
13PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingnegative regulation of BMP signaling pathwayAMPA glutamate receptor complexGO:0005615alcohol drinkingmathematical abilityinsomniametabolic syndrome
✦AI Summary

Based on limited published evidence, VWC2L (von Willebrand factor C domain containing 2 like) is a secreted cysteine knot protein that modulates bone and neural development. In osteoblasts, VWC2L accelerates matrix mineralization and increases Osterix expression, likely through TGF-β superfamily signaling 1. As a BMP antagonist of the Chordin family, VWC2L weakly inhibits BMP activity and promotes neurogenesis in neural precursor cells 2. The protein is expressed in brain tissue and ubiquitously across other tissues. VWC2L's functions align with its annotation for negative regulation of BMP signaling and involvement in neurogenesis and bone differentiation.

Sources cited
1
VWC2L promotes matrix mineralization in osteoblasts by increasing Osterix expression through TGF-β signaling pathway
PMID: 22209847
2
VWC2L (Brorin-like) is a BMP antagonist that promotes neurogenesis in neural precursor cells and is predominantly expressed in brain
PMID: 19852960
⚠Limited data available — This gene has 2 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
alcohol drinkingOpen Targets
0.44Moderate
mathematical abilityOpen Targets
0.39Weak
insomniaOpen Targets
0.37Weak
metabolic syndromeOpen Targets
0.32Weak
neurotic disorderOpen Targets
0.30Weak
liver diseaseOpen Targets
0.26Weak
complicationOpen Targets
0.18Weak
nervous system diseaseOpen Targets
0.18Weak
Myasthenia gravisOpen Targets
0.16Weak
VertigoOpen Targets
0.15Weak
adolescent idiopathic scoliosisOpen Targets
0.15Weak
chronic intestinal vascular insufficiencyOpen Targets
0.14Weak
attention deficit hyperactivity disorderOpen Targets
0.13Weak
diabetic ketoacidosisOpen Targets
0.12Weak
Herpes ZosterOpen Targets
0.12Weak
Benign Thyroid Gland NeoplasmOpen Targets
0.12Weak
autism spectrum disorderOpen Targets
0.11Weak
ocular hypotensionOpen Targets
0.10Weak
placenta praeviaOpen Targets
0.10Weak
nutritional deficiency diseaseOpen Targets
0.10Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SKOR1Shared pathway100%TRIM33Shared pathway50%SKOR2Shared pathway50%CHRDL2Shared pathway33%LEMD3Shared pathway33%VWC2Shared pathway33%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
2%
Lung
0%
Heart
0%
Ovary
0%
Liver
0%
Gene Interaction Network
Click a node to explore
VWC2LSKOR1TRIM33SKOR2CHRDL2LEMD3VWC2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt B2RUY7
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.74LoF Tolerant
pLIⓘ
0.18Tolerant
Observed/Expected LoF0.44 [0.27–0.74]
RankingsWhere VWC2L stands among ~20K protein-coding genes
  • #16,355of 20,598
    Most Researched13
  • #5,837of 17,882
    Most Constrained (LOEUF)0.74
Genes detectedVWC2L
Sources retrieved2 papers
Response time—
📄 Sources
2
1
Modulation of matrix mineralization by Vwc2-like protein and its novel splicing isoforms.
PMID: 22209847
Biochem Biophys Res Commun · 2012
1.00
2
A novel neural-specific BMP antagonist, Brorin-like, of the Chordin family.
PMID: 19852960
FEBS Lett · 2009
0.50